Participants needed in the CAN-BIND study
CANBIND Study Ad.jpgOur biomarker study (CAN-BIND) offers individuals with depression (18-65 years) treatment with a widely available anti-depressant (not a trial drug). The aim is to identify biological indicators of treatment response so that sometime in the future, we might be able to figure out early what medications are more likely to work for a particular person, and make better treatment decisions. Since the study involves a lot of participant time for interviews, blood work, MRI scans, EEG, etc., there is compensation – up to $400 per patient who completes the full study. If you are interested or require further […]